Host cell factors controlling type III secretion effector translocation

控制III型分泌效应器易位的宿主细胞因子

• 批准号: 10416972
• 负责人: Arne Rietsch
• 金额: $ 24.15万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-03-07 至 2024-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10416972
• 关键词: 5' Splice Site; Affect; Attenuated; Bacteria; Bacterial Attachment Site; Biochemical Pathway; CRISPR/Cas technology; Cell Line; Cell membrane; Cell physiology; Cell secretion; Cells; Disease; Docking; Down-Regulation; Ebola virus; Feedback; Gene Activation; Gene Expression; Genes; Genomics; Glycine decarboxylase; Goals; Haploid Cells; Haploidy; High-Throughput Nucleotide Sequencing; Hospitals; Human Cell Line; Immune; Immune system; Infection; Injections; Insertion Mutation; Integration Host Factors; Life Style; Light; Mediating; Molecular; Molecular Conformation; Molecular Machines; Mutagenesis; Mutation; Needles; Pathogenicity; Pathway interactions; Perforation; Phospholipase; Plasma Cells; Play; Process; Production; Proteins; Pseudomonas aeruginosa; Research; Resistance; Role; Site; Structure; Syringes; System; Toxin; Type III Secretion System Pathway; Ursidae Family; Work; base; cytotoxic; delivery vehicle; design; drug development; experimental study; gain of function; gain of function mutation; genome-wide; loss of function mutation; mortality; mutant; novel; overexpression; pathogen; promoter; secretion process; sensor; small molecule inhibitor

Abstract Type III secretion systems (T3SS) are intricate molecular machines that allow Gram-negative pathogens to directly inject effector proteins into host cells. While the arsenal of injected effector proteins varies among pathogens and supports a wide variety of pathogenic lifestyles, the core apparatus is conserved. A key feature of T3SSs is that effector translocation is triggered by host-cell contact. In order to inject proteins, the bacterium attaches to the host cell and uses the T3SS to insert pore-forming translocator proteins into the host cell plasma membrane. The tip of the needle is docked to this pore, forming the translocon. Host cell contact is sensed by a conformational change in the pore that is propagated to the base of the apparatus. While there is ample evidence that translocon assembly and function are modulated by the host cell, which cellular functions are involved, and what step in the translocation process they influence is poorly understood. We are proposing to perform a genome wide saturation mutagenesis selection in a haploid human cell line to identify cellular pathways that impact effector translocation by the Pseudomonas aeruginosa type III secretion system. We will employ a transposon that also harbors a constitutive promoter and splice donor site, which will allow us to not only identify loss of function mutations, but also gain of function mutations resulting from artificial production of a downstream gene. Moreover, we will take advantage of the P. aeruginosa system and perform the selection with either wild type bacteria or a mutant strain that does not require a specific host cell trigger to commence effector secretion. This will allow us to isolate the host cell process that triggers effector secretion. To achieve these goals, the application is divided into two specific aims. Aim 1 encompasses the selection for transposon insertion mutations that confer resistance to the P. aeruginosa T3SS, as well as the high throughput sequencing and analysis needed to identify candidate hits. In Aim 2 we will validate mutations we identify. Taken together this work will shed light on an understudied aspect of the type III secretion process: the contribution of the host cell to translocon function. By identifying both loss- and gain of function mutants, and by performing the selection in a haploid cell line, this project will be more comprehensive than any study performed to date. The design of the experiments also allows us to specifically identify factors contributing to triggering of effector secretion on host cell contact, a hallmark feature of type III secretion systems that remains a mystery to this day.

抽象的 III 型分泌系统 (T3SS) 是复杂的分子机器，允许革兰氏阴性病原体 将效应蛋白直接注射到宿主细胞中。虽然注射的效应蛋白库各不相同 病原体并支持多种致病生活方式，但核心装置是保守的。一个关键特征 T3SS 的一个特点是效应器易位是由宿主细胞接触触发的。为了注入蛋白质，细菌 附着在宿主细胞上，并使用 T3SS 将成孔易位蛋白插入宿主细胞血浆中 膜。针尖停靠在这个孔上，形成易位子。宿主细胞接触是由 孔中的构象变化传播到装置的底部。虽然有充足的证据 易位子的组装和功能是由宿主细胞调节的，其中涉及细胞功能，并且 人们对它们影响易位过程中的哪一步知之甚少。 我们建议在单倍体人类细胞中进行全基因组饱和诱变选择 用于识别影响 III 型铜绿假单胞菌效应器易位的细胞途径 分泌系统。我们将使用一个转座子，它也包含一个组成型启动子和剪接供体位点， 这将使我们不仅能够识别功能缺失突变，还能识别由此产生的功能突变 来自下游基因的人工生产。此外，我们将利用铜绿假单胞菌系统 并用野生型细​​菌或不需要特定宿主的突变菌株进行选择 细胞触发开始效应物分泌。这将使我们能够分离触发效应器的宿主细胞过程 分泌。为了实现这些目标，该应用程序分为两个具体目标。目标 1 包括 选择转座子插入突变，赋予对铜绿假单胞菌 T3SS 的抗性，以及 需要高通量测序和分析来识别候选命中。在目标 2 中，我们将验证突变 我们确定。 总而言之，这项工作将揭示 III 型分泌过程中一个尚未得到充分研究的方面： 宿主细胞对易位子功能的贡献。通过识别功能突变体的丧失和获得，并通过 在单倍体细胞系中进行选择，该项目将比任何进行的研究更全面 迄今为止。实验的设计还使我们能够具体识别导致触发的因素 宿主细胞接触时的效应物分泌，这是 III 型分泌系统的一个标志特征，但目前仍是一个谜。 这一天。